Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab Injections.

Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab Injections. Ophthalmol Retina. 2025 Apr; 9(4):330-342.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Angiogenesis Inhibitors
Drug Delivery Systems
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Intravitreal Injections
Male
Middle Aged
Ranibizumab
Retina
Subretinal Fluid
Tomography, Optical Coherence
Treatment Outcome
Vascular Endothelial Growth Factor A
Visual Acuity
Wet Macular Degeneration

authors with profiles

Veeral Sheth